Literature DB >> 16504853

Fatal hyperthermia due to dental treatment.

Izumi Noguchi1, Hideki Ohno, Koji Takano, Rikako Shimada, Mami Sasao, Hiroyuki Shimonaka.   

Abstract

A 12-year-old boy with mental retardation and cerebral palsy developed hyperthermia during dental treatment performed while he was conscious. During the treatment, he was highly excited, and shortly after completion of the procedure, general muscular spasms occurred. His axillary temperature was 41.6 degrees C then. He was transferred to another general hospital and there he was judged to have become afebrile and was discharged. His condition deteriorated during the night, and he was readmitted to the same hospital the following morning. The patient did not respond to the therapy and died from multiple organ failure on the 13th day. It was thought that hyperthermia had led to rhabdomyolysis and DIC. The cause of death is discussed. Hyperthermia in a handicapped patient is not always transient or benign, and can be life threatening.

Entities:  

Mesh:

Year:  2006        PMID: 16504853     DOI: 10.1016/j.tripleo.2005.07.001

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  3 in total

Review 1.  A systematic review of the use of local analgesia in medically compromised children and adolescents.

Authors:  A Dougall; M Hayes; B Daly
Journal:  Eur Arch Paediatr Dent       Date:  2017-10-05

2.  Effects of ulinastatin administered at different time points on the pathological morphologies of the lung tissues of rats with hyperthermia.

Authors:  Zai-Sheng Qin; Pei Tian; Xia Wu; Hong-Mei Yu; Na Guo
Journal:  Exp Ther Med       Date:  2014-04-01       Impact factor: 2.447

3.  Availability of a remote online hemodynamic monitoring system during treatment in a private dental office for medically high-risk patients.

Authors:  Shinya Yamazaki; Hiroyoshi Kawaai; Shigeo Sasaki; Kazuhiro Shimamura; Hiroshi Segawa; Takahiro Saito
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.